Notably, in the present study, we found that DRP1 inhibition synergistically enhances venetoclax-induced mitochondrial apoptosis via activation of BAX/BAK in TP53mut AML cell lines as well as in primary AML cells; however, it does not affect normal BMMCs. This evidence concerns the gene DNM1L and acute myeloid leukemia.